Arcus Biosciences Current Deferred Revenue (Quarterly) Analysis

Arcus Biosciences, Inc. (RCUS)

23.23 -0.10 (-0.43%) USD | NYSE | Dec 30, 16:00

23.22 0.00 (0.00%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for RCUS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Gilead Sciences, Inc.	--
Actinium Pharmaceuticals, Inc.	--
Madrigal Pharmaceuticals, Inc.	--
Karyopharm Therapeutics, Inc.	--
Janux Therapeutics, Inc.	--